Evan Hicks

Evan Hicks has over two decades of experience in various roles within the pharmaceutical and healthcare industry. Evan is currently working as the Vice President of Commercial Development & Marketing at Bicycle Therapeutics since 2023. Prior to this, they served as the Vice President of Commercial Development & Marketing at G1 Therapeutics, Inc. from 2018 to 2023. At G1 Therapeutics, Evan was also the Senior Brand Director and played a crucial role in the launch of COSELA (trilaciclib). Before joining G1 Therapeutics, Evan held positions at AstraZeneca, MedImmune, Human Genome Sciences, Johnson & Johnson, DuPont, Corporate Executive Board, and Accenture. Evan'sresponsibilities included marketing, brand strategy, team management, market research, forecasting, and launching various products and therapies. Overall, Evan has demonstrated a strong track record in commercial development, marketing, and brand management within the healthcare industry.

Evan Hicks' education history begins in 1994 when they attended Duke University and pursued a Bachelor's degree in Chemistry. Evan completed their undergraduate studies in 1998. Following that, from 2002 to 2003, Hicks attended the University of North Carolina at Chapel Hill, where they focused on Chemistry and obtained a Master's degree. Moving forward to 2003, Hicks enrolled in Duke University's The Fuqua School of Business and pursued an MBA with a specialization in Marketing. Evan successfully completed their MBA program in 2005.